ActRO Co (290740) Fair Value & Analysis
Technology · KR · Market cap 108B KRW
Fair value as of: Jun 24, 2026
Analysis
ActRO Co (290740) currently trades at 9,650 KRW, while our model-based Fair Value estimate is 16,084 KRW — implying the stock looks roughly 66.7% undervalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
ActRO Co., Ltd, together with its subsidiaries, manufactures and sells mobile lens automation equipment in South Korea and Vietnam. The company offers auto focusing actuator, folded zoom actuator, and optical image stabilizer; dual actuator and OIS/CLAF/AF performance testers; precision jig; high aspect ratio plating coil; anode materials; and terahertz inspection system. It also provides assembly parts, such as grease dispense and inspection, ball complexer, AF stopper assy, prism inspection, magnet assy, bonding, carrier loading, and FPCB attach machines; and cleaning parts comprising air blowing, water cleaning, and carbon dioxide cleaning and packing machines. The company was formerly known as Uniq Co., Ltd and changed its name to ActRO Co., Ltd in January 2016. ActRO Co., Ltd was founded in 2012 and is headquartered in Yongin-si, South Korea.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is ActRO Co (290740) undervalued?
What is the fair value of 290740?
What is the quality score of 290740?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.